Read + Share
Amedeo Smart
Independent Medical Education
Pasternak B, Wintzell V, Eliasson B, Svensson AM, et al. Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study. Diabetes Care 2020;43:1326-1335.PMID: 32295809
Email
LinkedIn
Facebook
Twitter
Privacy Policy